Form 4: Abeona Therapeutics CFO Joseph Vazzano Reports Stock Disposal to Cover Tax Obligations
SEC Form 4 Filing
Chief Financial Officer of Abeona Therapeutics, Joseph Vazzano, disposed of 703 shares of common stock to cover tax obligations related to vesting restricted stock.
Summary
- On March 15, 2024, Joseph Vazzano, the Chief Financial Officer of Abeona Therapeutics, reported a transaction involving the disposal of 703 shares of common stock.
- The shares were surrendered to satisfy tax withholding obligations upon the vesting of restricted stock.
- The transaction was executed at a price of $8.14 per share.
- Following the transaction, Vazzano directly owns 228,260 shares of Abeona Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by a company insider, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of stock disposal transaction and vesting of restricted stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.